跳至主要内容
临床试验/NCT02704780
NCT02704780已完成2 期

Umbilical Vein Injection of 800µg Misoprostol Versus 400 µg Misoprostol in the Treatment of Retained Placenta: A Multicenter, Randomized Double Blind Controlled Trial

Hawler Medical University1 个研究点 分布在 1 个国家目标入组 509 人开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
509
试验地点
1
主要终点
Delivery of placenta after injection of of 400 Microgram intraumbilical misoprostol versus 800 microgram of misoprostol

研究概览

简要总结

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

详细描述

The third stage of labor may be complicated by retained placenta, which may cause severe bleeding and infection, with a potentially fatal outcome. Manual removal of placenta is the current standard of management of retained placenta which usually requires general or regional anaesthesia at a hospital and it is an invasive procedure that may lead to bleeding, trauma and infection. Intraumbilical injection of uterotonic agent( misoprostol) is an easy, non invasive procedure. A randomized clinical trial are required to determine the difference between two doses of misoprostol 400 versus 800 micro gram for management of retained placenta

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • women with a singleton pregnancy, delivered vaginally
  • 28 weeks of gestation and more,
  • had a prolonged third stage of labor (more than 30 minutes) despite active management,
  • Haemodynamically stable and accept to participate in the trial

排除标准

  • multiple pregnancies,
  • previous caesarean delivery,
  • haemodynamically instability, severe anaemia (haemoglobin concentration <8 g/dL),
  • chorioamnionitis
  • Refused to participate in the trial

研究组 & 干预措施

400 Microgram Misoprostol

Active Comparator

Misoprostol 400 micro-gram dissolved in 20 mL normal saline will be injected in the umbilical vein in the first group

干预措施: Misoprostol (Drug)

800 Microgram Misoprostol

Active Comparator

Misoprostol 800 micro-gram dissolved in 20 mL normal saline will be injected in umbilical cord of the second group

干预措施: Misoprostol (Drug)

结局指标

主要结局

Delivery of placenta after injection of of 400 Microgram intraumbilical misoprostol versus 800 microgram of misoprostol

时间窗: up to 30 minutes after intraumbilical injection

complete delivery of placenta after injection of intraumbilical misoprostol

次要结局

  • side effects of misoprostol(up to 24 hours after delivery of placenta)
  • The amount of blood loss vaginally in both groups(up to 30 minutes after injection of placenta)
  • The time of delivery of placenta in both groups(up to 30 minutes after delivery of the placenta)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shahla Alalaf

Professor Shahla K.Alalaf

Hawler Medical University

研究点 (1)

Loading locations...

相似试验

Two Different Regimens of Misoprostol in Retained... | 临床试验